Data / Form D filings / AesRx, LLC
AesRx, LLC: Form D filings
AesRx, LLC, a biotechnology company in Newton, MA, filed 8 Form D notices with the SEC between 2011 and 2013. The latest, on December 10, 2013, reports $600,000 sold of a $750,000 offering to 18 investors.
Find out what AesRx, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 275 GROVE STREET, SUITE 2-400, Newton, MA, 02466
- Phone
- (617) 965-2521
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1521095
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 10, 2013 | New notice | $750,000 | $600,000 | $150,000 | 18 | Nov 25, 2013 | sec.gov |
| May 9, 2013 | Amendment | $1,535,150 | $1,355,150 | $180,000 | 22 | Aug 27, 2012 | sec.gov |
| Apr 9, 2013 | Amendment | $1,535,150 | $1,280,150 | $255,000 | 20 | Aug 27, 2012 | sec.gov |
| Dec 20, 2012 | Amendment | $1,350,000 | $958,500 | $391,500 | 19 | Aug 27, 2012 | sec.gov |
| Oct 9, 2012 | Amendment | $1,350,000 | $550,000 | $800,000 | 12 | Aug 27, 2012 | sec.gov |
| Sep 10, 2012 | New notice | $1,350,000 | $525,000 | $825,000 | 11 | Aug 27, 2012 | sec.gov |
| Jun 30, 2011 | Amendment | $3,500,000 | $1,505,000 | $1,995,000 | 8 | May 6, 2011 | sec.gov |
| May 20, 2011 | New notice | $3,500,000 | $1,375,000 | $2,125,000 | 2 | May 6, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Maggie R. LeFlore | Director | |
| Stephen R. Seiler | Executive Officer, Director | |
| R. John K. Fletcher | Director | |
| Colin R. Hill | Director | |
| Mary K. Pendergast | Director |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
Every Form D from the week of Dec 9, 2013 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AesRx, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.